These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 14337916)

  • 1. [EXPERIENCES WITH HIGH-DOSED SEGOTIN TREATMENT].
    RAHNFELD G
    Ther Ggw; 1964 Sep; 103():1156-61. PubMed ID: 14337916
    [No Abstract]   [Full Text] [Related]  

  • 2. [EXPERIENCES WITH THE NEW CORONARY VASODILATOR SYNADRIN. CLINICAL CONTROL AND ELECTROCARDIOGRAPHY OF THE TREATED CASES].
    BERJILLOSCORDON M; BELLIDOGAMEZ JA; PELAEZGOMEZ A
    Rev Clin Esp; 1964 Jul; 94():24-41. PubMed ID: 14179918
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experiences with the coronary drug SA30].
    WALTHER H
    Z Gesamte Inn Med; 1963 May; 18():394-8. PubMed ID: 13998721
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences with the clinical use of Segontin in coronary disease].
    OHIRA I; HAGIWARA M; UMEZONO T; TSUCHIYA T; IMAGAWA S; MATSUOKA K
    Chiryo; 1962 Aug; 44():1573-7. PubMed ID: 14481363
    [No Abstract]   [Full Text] [Related]  

  • 5. [PPDPA (PHENYLPROPYLDIPHENYLPROPYLAMINE) IN CORONARY INSUFFICIENCY].
    ASTALDI G; MEARDI G
    Minerva Med; 1965 Jun; 56():2168-73. PubMed ID: 14328098
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experiences with segontin].
    RATSCHOW M; SCHOOP W
    Med Klin; 1960 Aug; 55():1421-3. PubMed ID: 14436429
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiences with segontin in internal medical practice].
    MENZEL M
    Ther Ggw; 1960 Sep; 99():432-4. PubMed ID: 13769511
    [No Abstract]   [Full Text] [Related]  

  • 8. [OBSERVATIONS ON THERAPY OF CORONARY DISEASE WITH PHENYLPROPYLDIPHENYLPROPYLAMINE].
    ZANETTIN G
    Gazz Int Med Chir; 1964 Apr; 68():690-7. PubMed ID: 14145735
    [No Abstract]   [Full Text] [Related]  

  • 9. [TREATMENT OF THE ANGINAL SYNDROME AND CORONARY INSUFFICIENCY WITH HOSTAGINAN].
    FRANCO R; ZUVIRIA EM
    Sem Med; 1964 Mar; 124():481-91. PubMed ID: 14157417
    [No Abstract]   [Full Text] [Related]  

  • 10. [PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE (SEGONTIN) IN TREATMENT OF SYNDROMES DUE TO CORONARY INSUFFICIENCY IN PATIENTS OVER SEVENTY].
    FRANZINI C; TURRI C; MONTEROSSO A
    Minerva Cardioangiol; 1964 Dec; 12():515-27. PubMed ID: 14269033
    [No Abstract]   [Full Text] [Related]  

  • 11. [CLINICO-ELECTROCARDIOGRAPHIC OBSERVATIONS ON THE ACTIVITY OF N-(3)-PHENYLPROPYL-(2)-1,1-DIPHENYL-PROPYL-(3)-AMINE (F.P.D.P.A.) IN CORONARY INSUFFICIENCY].
    MENCI S
    Gazz Int Med Chir; 1964 Jan; 68():98-109. PubMed ID: 14123796
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prenylamine in the therapy of coronary disease].
    Villani M
    Minerva Med; 1973 Mar; 64(20):1020-2. PubMed ID: 4704729
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical comparative study of perexiline maleate and prenylamine in the treatment of chronic coronary insufficiency].
    Labriola E
    Clin Ter; 1975 Feb; 72(4):337-51. PubMed ID: 1222513
    [No Abstract]   [Full Text] [Related]  

  • 14. [CLINICAL TRIALS WITH PHENYL-DIPHENYL-PROPYL-AMINE IN CORONARY INSUFFICIENCY].
    TRILLA SANCHEZ E; BELLONCANEIRO JM; TORNER SOLER M
    Rev Esp Cardiol; 1963 Oct; 16():873-84. PubMed ID: 14117507
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dosed physical loading as a method of evaluating the results of treating ischemic heart disease].
    Ol'binskaia LI; Ovchinnikova LV
    Kardiologiia; 1972 Dec; 12(12):32-6. PubMed ID: 4196637
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment with phenyl-propyl-diphenyl-propyl-amine (Segontin Hoechst) in coronary disease].
    DOBREANU-ENESCU V; TEODORINI S; HARNAGEA P
    Stud Cercet Med Interna; 1963; 4():243-53. PubMed ID: 14028230
    [No Abstract]   [Full Text] [Related]  

  • 17. [Our experiences with current Corontin preparations].
    Várkonyi G
    Orv Hetil; 1967 Jul; 108(29):1363-4. PubMed ID: 6081970
    [No Abstract]   [Full Text] [Related]  

  • 18. [METABOLIC EFFECTS OF PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE IN THE HEALTHY MAN AND IN THE PATIENT WITH ISCHEMIC HEART DISEASE. I. CLINICAL AND EXPERIMENTAL PHARMACOLOGY OF FEDIPRA].
    ZOLI A; BRAT A; GIARDINA A
    Riv Crit Clin Med; 1963 Apr; 63():75-90. PubMed ID: 14277814
    [No Abstract]   [Full Text] [Related]  

  • 19. [CLINICAL CONSIDERATIONS ON SOME PECULIAR PHARMACOLOGICAL EFFECTS OF PHENYLPROPYLDIPHENYLPROPYLAMINE].
    DELGUERCIO R
    Minerva Med; 1964 Sep; 55():2805-7. PubMed ID: 14199469
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of coronary insufficiency].
    NANBA H
    Sogo Rinsho; 1963 Jul; 12():1378-85. PubMed ID: 13937539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.